F065 Botulinum Toxins: The Latest Updates
DESCRIPTION
Botulinum Toxin use has advanced significantly since its introduction in aesthetics. There are currently multiple decisions to be made regarding the type of BNTA products to be used, injection techniques, and indications. This forum aims to examine where we came from and what is new in understanding our clinical use of neuromodulators. We will present data on the similarities and differences in those drugs both available and soon to be available, as well as anatomy related to injections and new injection techniques. Reconstitution variations and psychosocial impacts on patients will also be highlighted.
LEARNING OBJECTIVES
Discriminate between the various neuromodulators on the market
Determine ideal injection techniques and anatomic safety zones to obtain the maximum efficacy
Appreciate the objective and subjective outcomes of neuromodulator treatments on patients
DIRECTOR
Joely Kaufman, MD, FAAD
SPEAKERS
Chytra V. Anand, MBBS, MSc, IFAAD
Vince Bertucci, MD, FAAD
Doris M Hexsel, MD, IFAAD
Seth L. Matarasso, MD, FAAD
DISCLOSURES
Chytra V. Anand, MBBS, MSc, IFAAD
Allergan Aesthetics – Consultant (1099 relationship)(Fees); Alma Lasers – Speaker/Faculty Education(Fees); Merz Aesthetics – Other(No Compensation Received);
Vince Bertucci, MD, FAAD
Allergan, Inc – Consultant (1099 relationship)(Fees); Allergan, Inc. – Advisory Board(Fees), Investigator(Fees), Speaker(Honoraria); AMNI Aesthetic Medicine Network Inc. – Consultant(Honoraria); Caliway Biopharmaceuticals Co., Ltd – Investigator(Fees); Clarion Medical Technologies – Speaker(Honoraria); Evolus, Inc. – Advisory Board(Fees), Speaker(Honoraria); Galderma Canada, Inc – Speaker(Honoraria); Galderma Laboratories, L.P. – Advisory Board(Fees); Galderma USA – Investigator(Fees); Hydrafacial – Advisory Board(Fees); L'Oreal – Advisory Board(Fees), Consultant (1099 relationship)(Fees); Medscape – Speaker/Faculty Education(Fees); Revance Therapeutics, Inc. – Advisory Board(Fees);
Doris M Hexsel, MD, IFAAD
No financial relationships exist with ineligible companies.
Joely Kaufman, MD, FAAD
Allergan, Inc – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Alphaeon – Stockholder(No Compensation Received); Galderma USA – Advisory Board(Honoraria), Investigator(Fees); Jetema – Investigator(Grants/Research Funding); Johnson and Johnson – Investigator(Grants/Research Funding); L'Oreal – Investigator(Grants/Research Funding); Merz Pharmaceuticals, LLC – Investigator(Grants/Research Funding); Neutrogena Corporation – Advisory Board(Honoraria); OneSkin – Consultant (1099 relationship)(Honoraria); Revance Therapeutics, Inc. – Investigator(Fees); Silk Medical Aesthetics Inc. – Investigator(Grants/Research Funding); TEOXANE Laboratories – Investigator(Fees);
Seth L. Matarasso, MD, FAAD
No financial relationships exist with ineligible companies.